Core Viewpoint - Yabao Chemical (300261) has shown significant improvement in its operational performance in the first half of 2025, with revenue reaching 662 million yuan, a year-on-year increase of 12.3%, and a narrowed net loss of 8.67 million yuan, down 83% from the previous year, primarily driven by the recovery of its pesticide intermediate business and effective cost control measures [1][2]. Group 1: Financial Performance - The company achieved a revenue of 662 million yuan in the first half of 2025, reflecting a 12.3% year-on-year growth [1]. - The net loss attributable to shareholders was 8.67 million yuan, which represents an 83% reduction compared to the same period last year [1]. Group 2: Business Recovery and Strategy - The pesticide segment has shown a significant recovery, with a substantial increase in orders quarter-on-quarter, attributed to strategic investments made over the past two to three years [1]. - The company has established deep collaborations with major agricultural enterprises such as Corteva, Bayer, and FMC, leading to the successful implementation of innovative pesticide intermediates and active ingredients [1]. Group 3: Pharmaceutical Business Development - Yabao Chemical has made notable progress in its pharmaceutical business by forming a strategic partnership with leading domestic innovative drug company Heng Rui Medicine (600276), focusing on areas such as oncology, metabolism, and cardiovascular diseases [1]. - This collaboration is expected to enhance Yabao Chemical's competitiveness in the pharmaceutical industry and expand its market presence in pharmaceutical intermediates and active pharmaceutical ingredients [1]. Group 4: R&D Investment - The company increased its R&D expenditure to 58.19 million yuan in the first half of 2025, marking a 49.46% year-on-year increase [2]. - Yabao Chemical emphasizes long-term commitment to R&D innovation, effectively applying green technologies such as continuous flow technology and biocatalysis in its pesticide and pharmaceutical CDMO businesses [2]. Group 5: Future Outlook - With ongoing increases in R&D investment, continuous capacity release in the pesticide business, and expansion in the pharmaceutical sector, Yabao Chemical is positioned to achieve sustainable growth and stand out in a competitive market [2].

Company Performance - Yabao Chemical (SZ 300261) reported a revenue of approximately 662 million yuan for the first half of 2025, representing a year-on-year increase of 12.31% [1] - The net loss attributable to shareholders was approximately 8.67 million yuan, with a basic earnings per share loss of 0.009 yuan [1] - In comparison, for the same period in 2024, the revenue was approximately 589 million yuan, with a net loss of about 52.01 million yuan and a basic earnings per share loss of 0.0541 yuan [1] Industry Insights - The pet industry is experiencing significant growth, with a market size of 300 billion yuan, leading to a surge in stock prices for related companies [1]

证券之星消息，雅本化学2025年中报显示，公司主营收入6.62亿元，同比上升12.31%；归母净利 润-866.84万元，同比上升83.33%；扣非净利润-1877.14万元，同比上升62.02%；其中2025年第二季度， 公司单季度主营收入3.46亿元，同比下降6.29%；单季度归母净利润408.81万元，同比上升163.51%；单 季度扣非净利润-448.17万元，同比上升49.49%；负债率47.75%，投资收益-146.27万元，财务费用-71.11 万元，毛利率19.26%。 财报数据概要请见下图: 2023 2024 2025 ■ 营业总收入-中报(亿) ■ 单季度营业总收入-第二季度(亿) 一 归母净利润 一 归母净利润-中报(万) -866.84 同比 +83.33% 单季度归母净利润-第二季度(万) 408.81 目比 +163.50% 9674.12 4352.59 408.8 -643.69 -866.84 -5201.36 2023 2025 ■ 单季度归母净利润-第二季度(万) ■ 归母净利润-中报(万) 一 扣非净利润 一 扣非净利润-中报(万) -1877.14 同比 +62.0 ...

证券代码：300261 证券简称：雅本化学 公告编号：2025-062 雅本化学股份有限公司 第六届董事会第六次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 一、审议通过了《关于<2025 年半年度报告>及其摘要的议案》 经审阅，董事会认为公司编制的《2025 年半年度报告》及《2025 年半年度报告 摘要》内容真实、准确、完整地反映了公司 2025 年上半年的实际经营情况，不存在 任何虚假记载、误导性陈述或者重大遗漏。本议案已经公司董事会审计委员会审议 通过。详见中国证监会指定信息披露网站刊登的公告。 表决结果：赞成8票，反对0票，弃权0票。 特此公告。 雅本化学股份有限公司 董事会 二〇二五年八月二十七日 雅本化学股份有限公司(以下简称"公司")第六届董事会第六次会议于 2025 年 8 月 25 日上午 10:30 以现场结合通讯方式召开，会议通知已于 2025 年 8 月 15 日以 邮件方式送达全体董事。本次会议应出席董事 8 名，实际出席会议董事 8 名。会议 由公司董事长兼总经理蔡彤先生主持，部分高级管理人员列席了会议。本次会议 ...

雅本化学股份有限公司 2025 年半年度报告全文 雅本化学股份有限公司 ABA CHEMICALS CORPORATION 2025 年半年度报告 股票代码：300261 股票简称：雅本化学 披露日期：2025 年 8 月 27 日 1 雅本化学股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、董事及高级管理人员保证半年度报告内容的真实、准确、 完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法 律责任。 公司负责人蔡彤、主管会计工作负责人王爱军及会计机构负责人(会计主 管人员)汤小新声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 公司存在市场竞争加剧风险、新项目投资建设风险、汇率风险，详细内容 见本报告"第三节 管理层讨论与分析"之"十、公司面临的风险和应对措施" 部分。敬请广大投资者注意投资风险。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 | 第二节 | 公司简介和主要财务指标 | 7 | | --- | --- | --- | | 第三节 | 管理层讨论与分析 | 10 | | 第四 ...

| 附件： | | | | 2025年半年度非经营性资金占用及其他关联资金往来情况汇总表 | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 编制单位：雅本化学股份有限公司 | | | | | | | | | 单位:万元 | | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公司的关 联关系 | 上市公司核算 的会计科目 | 2025年期初占 用资金余额 | 2025年1-6月占用 累计发生金额（不 含利息） | 2025年1-6月占用 资金的利息（如 有） | 2025年1-6月偿 还累计发生金额 | 2025年6月末占 占用形成原 用资金余额 因 | 占用性质 | | 控股股东、实际控制人及其附属企业 | | | | | | | | | 非经营性占用 | | | | | | | | | | | 非经营性占用 | | 小计 | | | | | | | | | — | | 前控股股东、实际控制人及其附属企业 | | | | | | | | | 非经营性占用 | | 小计 | | | | | | | | ...

Group 1 - The core point of the article is that Yabn Chemical reported a revenue of 662 million yuan for the first half of 2025, representing a year-on-year growth of 12.31% [1] - The net loss attributable to shareholders of the listed company was 8.6684 million yuan, compared to a net loss of 52.0136 million yuan in the same period last year [1]

证券日报网讯雅本化学（300261）8月22日在互动平台回答投资者提问时表示，截至2025年8月20日，公 司股东总数为56220户。 ...

Core Viewpoint - The agricultural chemical sector experienced a rise of 1.83% on August 20, with Jiangshan Co., Ltd. leading the gains [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 3766.21, up 1.04% [1]. - The Shenzhen Component Index closed at 11926.74, up 0.89% [1]. Group 2: Individual Stock Performance - Jiangshan Co., Ltd. (600389) closed at 24.66, with a gain of 5.61% and a trading volume of 141,200 shares, amounting to a transaction value of 342 million yuan [1]. - Yuntianhua Co., Ltd. (600096) closed at 26.95, up 5.27%, with a trading volume of 490,900 shares and a transaction value of 1.318 billion yuan [1]. - Xin'an Chemical Industry Co., Ltd. (600596) closed at 10.71, gaining 4.18%, with a trading volume of 461,300 shares and a transaction value of 483 million yuan [1]. - Batian Ecological Engineering Co., Ltd. (002170) closed at 10.49, up 3.96%, with a trading volume of 683,100 shares and a transaction value of 717 million yuan [1]. - Hubei Xuanhua Co., Ltd. (000422) closed at 13.75, gaining 3.38%, with a trading volume of 469,200 shares and a transaction value of 637 million yuan [1]. - Xianda Co., Ltd. (603086) closed at 10.57, up 3.12%, with a trading volume of 851,100 shares and a transaction value of 907 million yuan [1]. - New Agricultural Co., Ltd. (002942) closed at 19.91, gaining 3.00%, with a trading volume of 45,100 shares and a transaction value of 8.86 million yuan [1]. - Stanley Co., Ltd. (002588) closed at 9.63, up 2.77%, with a trading volume of 141,200 shares [1]. - Xingfa Group (600141) closed at 25.83, gaining 2.70%, with a trading volume of 188,300 shares and a transaction value of 484 million yuan [1]. - Runfeng Co., Ltd. (301035) closed at 68.50, up 2.70%, with a trading volume of 13,500 shares and a transaction value of 90.67 million yuan [1]. Group 3: Fund Flow Analysis - The agricultural chemical sector saw a net outflow of 82.02 million yuan from main funds, while speculative funds experienced a net inflow of 277 million yuan, and retail investors had a net outflow of 195 million yuan [2].

证券日报网讯雅本化学（300261）8月18日在互动平台回答投资者提问时表示，截至2025年8月10日，公 司股东总数为56385户。 ...